U.S. Bank, a leading financial services provider, has announced the completion of its acquisition of Salucro Healthcare Solutions LLC, a Tempe, Arizona-based company specializing in healthcare financial technology. This move underscores U.S. Bank’s commitment to enhancing its offerings within the healthcare sector, particularly in the realm of patient billing and payments.
Why it matters: The acquisition strengthens U.S. Bank’s position in the healthcare financial technology sector, potentially impacting how healthcare providers and patients manage billing and payments.
The big picture: As healthcare costs continue to rise, efficient payment solutions become increasingly crucial for both providers and patients. This move by U.S. Bank reflects a growing trend of financial institutions investing in specialized healthcare fintech.
Driving the news: Salucro, founded in 2004, has been at the forefront of developing innovative online billing and payment solutions tailored for healthcare providers across the United States. The company’s flagship platform, MedEpay, has been a cornerstone in streamlining financial transactions between healthcare providers and patients. Initially marketed in partnership with Elavon, a U.S. Bank subsidiary and a global leader in payment processing, MedEpay has gained significant traction in the healthcare industry.
What they’re saying: “U.S. Bank is a leader in providing banking and payments services to the healthcare industry, making it easier for providers and patients to focus on what’s most important to them,” said Shailesh Kotwal, Vice Chair of U.S. Bank Payment Services. “Salucro’s robust billing and payment platform is an ideal complement to the offerings we provide throughout U.S. Bank and Elavon.”
Between the lines:
